J. Michael Pearson | |
---|---|
Born | 1959 (age 64–65) London, Ontario, Canada |
Nationality | Canadian[1] |
Alma mater | Duke University (BS & BSE) University of Virginia (MBA) |
Known for | Former CEO of Valeant Pharmaceuticals |
Spouse | Christine Pearson |
Children | 4 |
J. Michael Pearson (born 1959) is a Canadian American[1] pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International[2][3] after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016.[4]
On April 27, 2016, Pearson, Bill Ackman and Howard Schiller appeared before the United States Senate Special Committee on Aging to answer concerns over the repercussions for patients and the health care system whom are affected by Valeant's business model.[5]
In 2017, Pearson sued Valeant Pharmaceuticals for $31 million as compensation for his alleged wrongful termination as CEO and chairman.[6] In December 2017, a New Jersey judge ruled that Pearson should pursue his claim by arbitration rather than through the courts.[7]